Holen Sie sich die Stockscreener-App
148.62
0.27%
0.40
Handel nachbörslich:
143.00
-5.62
-3.78%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$148.22
Offen:
$148.395
24-Stunden-Volumen:
4.00M
Relative Volume:
1.60
Marktkapitalisierung:
$36.28B
Einnahmen:
$222.29B
Nettoeinkommen (Verlust:
$1.56B
KGV:
23.19
EPS:
6.41
Netto-Cashflow:
$2.44B
1W Leistung:
-2.22%
1M Leistung:
+12.79%
6M Leistung:
+20.33%
1J Leistung:
+49.32%
1-Tages-Spanne:
$142.94
$148.92
1-Wochen-Bereich:
$142.94
$154.07
52-Wochen-Spanne:
$93.17
$154.07
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
148.62 | 36.28B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
687.52 | 88.38B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
278.38 | 56.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
70.47 | 8.10B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.15 | 626.70M | 10.42B | -38.77M | 323.54M | -0.51 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health (CAH): Navigating Market Uncertainty | CAH Stock News - GuruFocus
Cardinal Health (CAH) Faces Market Focus Amid Global Trade Talks - GuruFocus
JPMorgan Adjusts Cardinal Health Price Target to $156 From $145, Maintains Neutral Rating - marketscreener.com
Cardinal Health's (NYSE:CAH) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5107 - Yahoo Finance
Cardinal Health, Inc. (CAH): Among Billionaire Mason Hawkins’ Mid-Cap Stocks with Huge Upside Potential - Insider Monkey
-Charles River agrees with Elliott to add new directors, review business - marketscreener.com
Charles River to add new directors, review business in agreement with Elliott - marketscreener.com
Cardinal Health releases new report on the cell and gene therapy industry | CAH Stock News - GuruFocus
Cardinal Health releases new report on the cell and gene therapy industry - Stock Titan
Cardinal Health (NYSE:CAH) Announces Dividend Increase to US$1 Per Share - simplywall.st
Cardinal Health Board of Directors Approves Quarterly Dividend | - GuruFocus
Cardinal Health (CAH) Boosts Quarterly Dividend and Revises Earnings Guidance - GuruFocus
Cardinal Health Raises Dividend by About 1% - MarketWatch
Cardinal Health raises quarterly dividend to $0.5107 By Investing.com - Investing.com Canada
Cardinal Health Board of Directors Approves Quarterly Dividend - GuruFocus
Cardinal Health Increases Quarterly Dividend to $0.5107 a Share From $0.5056, Payable July 15 to Investors of Record July 1 - marketscreener.com
Cardinal Health Board of Directors Approves Quarterly Dividend | CAH Stock News - GuruFocus
Cardinal Health (CAH) Stock Target Price Increased by Morgan Stanley | CAH Stock News - GuruFocus
Argus Elevates Price Target for Cardinal Health (CAH) Amid Strat - GuruFocus
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Cardinal Health (CAH) Price Target Increased by Morgan Stanley | - GuruFocus
Argus Adjusts Price Target on Cardinal Health to $162 From $148 - marketscreener.com
Cardinal Health’s Promising Growth Under New Leadership Justifies Buy Rating - TipRanks
Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May - Seeking Alpha
Cardinal Health Third Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Cardinal Health (CAH): Analyst Raises Price Target Amid Strong P - GuruFocus
Cardinal Health (CAH): Analyst Raises Price Target Amid Strong Performance | CAH Stock News - GuruFocus
Cardinal Health cuts employees to offset up to $300M tariff charge - MedTech Dive
Cardinal Health CEO Jason Hollar on rising profits, record stock price - The Business Journals
Cardinal Health reports Q3 results, raises 2025 outlook - Drug Store News
UBS Elevates Price Target for Cardinal Health (CAH) to $170 | CA - GuruFocus
Cardinal Health (CAH) Price Target Raised by Baird Analyst | CAH Stock News - GuruFocus
UBS Elevates Price Target for Cardinal Health (CAH) to $170 | CAH Stock News - GuruFocus
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - Yahoo Finance
Cardinal Health (CAH) Price Target Increased by Baird Analyst | - GuruFocus
Cardinal Health, Inc. (NYSE:CAH) Q3 2025 Earnings Call Transcript - MSN
Cardinal Health (CAH) Price Target Increased by Baird Analyst | CAH Stock News - GuruFocus
Cardinal Health Reaches Analyst Target Price - Nasdaq
Medtech companies try to head off price increases after tariffs - Modern Healthcare
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health Inc (CAH) Q3 2025 Earnings Call Highlights: Strong Earnings Growth and Raised ... - Yahoo Finance
Cardinal Health Inc (CAH) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks - AOL.com
Cardinal Health Inc (CAH) Q3 2025 Earnings Call Highlights: Strong Earnings Growth and Raised Guidance - GuruFocus
Cardinal Health raises FY 2025 EPS guidance to $8.05-$8.15 amid strong pharma growth and acquisitions - MSN
Cardinal Health (CAH) Boosts 2025 Outlook Following Strong Q3 - GuruFocus
Cardinal Health’s Earnings Call Highlights Growth and Challenges - TipRanks
Citi Increases Price Target for Cardinal Health (CAH) After Robu - GuruFocus
Citi Increases Price Target for Cardinal Health (CAH) After Robust Q3 Performance | CAH Stock News - GuruFocus
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results a - GuruFocus
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.63%
2.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):